>>Can someone tell me what the actual relationship is between Celldex and Dr Wong and their rights to his vaccines? I know Medx and Cege have trials ongoing, are we going to do the same with Celldex?<<
It would appear Thomas Jefferson University and the NIH may have an interest:
patft.uspto.gov
There's not much to go on aside from the website and the S-1 and progeny. Celldex got the technology through the acquisition of Alteris -- where Dr. Wong was the CSO, & it appears the IP came with it. From the latest Celldex S-1/A, the section that deals with Alteris' point of view (hence, "we" means Alteris): "In January 2005, we entered into an asset purchase agreement to sell substantially all our non current assets and assign our exclusive licenses from Duke University, The Johns Hopkins University and Thomas Jefferson University to Celldex Therapeutics, Inc." The Alteris website is still kind of there, but if one clicks on the "intellectual property" link, nothing shows up.
alteristhera.com
You may have done all this poking around already, and that's why you're asking us. But I'd guess we're all clueless, aside from the above, so . . .
Your best bet for details would be to call/email Celldex IR with your question.
Welcome to SI!
Cheers, Tuck |
